Rocket Pharmaceuticals (RCKT) EPS (Basic) (2014 - 2026)
Rocket Pharmaceuticals (RCKT) posted EPS (Basic) of -$0.42 for Q1 2026, down 10.88% sequentially from -$0.38 in Q4 2025, and up 23.81% YoY from -$0.34 in Q1 2025.
Powered by 
Analysis
Rocket Pharmaceuticals (RCKT) EPS (Basic) (2014 - 2026) Analysis & Trends
Rocket Pharmaceuticals has reported EPS (Basic) for 13 years, with the latest figure at -$0.42 in Q1 2026.
- Quarterly EPS (Basic) rose 23.81% year-over-year to -$0.42 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.87 (up 20.33% YoY) and the FY2025 annual result came in at -$2.01, up 26.43% from the prior year.
- EPS (Basic) declined to -$0.42 in Q1 2026 per RCKT's latest filing, from -$0.38 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.38 in Q4 2025 and troughed at -$0.98 in Q4 2022.
- A 5-year average of -$0.68 and a median of -$0.71 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2025: EPS (Basic) slumped 51.76% in 2022, then jumped 39.84% in 2025.
- Over 5 years, EPS (Basic) stood at -$0.98 in 2022, then climbed by 27.47% to -$0.71 in 2023, then increased by 10.4% to -$0.64 in 2024, then surged by 39.84% to -$0.38 in 2025, then dropped by 10.88% to -$0.42 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.42, -$0.38, and -$0.45 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Rocket Pharmaceuticals | 437.27 Mn | 437.27 Mn | - | 1.09 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.09 |
| Mar 31, 2026 | -0.42 |
| Dec 31, 2025 | -0.38 |
| Sep 30, 2025 | -0.45 |
| Jun 30, 2025 | -0.62 |
| Mar 31, 2025 | -0.56 |
| Dec 31, 2024 | -0.64 |
| Sep 30, 2024 | -0.71 |
| Jun 30, 2024 | -0.74 |
| Mar 31, 2024 | -0.66 |
| Dec 31, 2023 | -0.71 |
| Sep 30, 2023 | -0.75 |
| Jun 30, 2023 | -0.82 |
| Mar 31, 2023 | -0.73 |
| Dec 31, 2022 | -0.98 |
| Sep 30, 2022 | -0.87 |
| Jun 30, 2022 | -0.83 |
| Mar 31, 2022 | -0.67 |
| Dec 31, 2021 | -0.70 |
| Sep 30, 2021 | -0.79 |